Loading...
OTC Markets
Totals
Securities
12,303
Dollar Vol
$2.3B
Share Vol
3.5B
Trades
300,911

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

RHHBY
Roche Holding Ltd

Sponsored ADR (1 ADS : 0.125 Ordinary)

41.95

0.86

2.09%

41.91 / 41.95 (3600 x 8997)

Real-Time Best Bid & Ask: 05:00pm 06/12/2025
Delayed (15 Min) Trade Data: 03:59pm 06/12/2025

Roche Holding Ltd

Grenzacherstrasse 124

Basel 4070

Switzerland

Principal Executive Offices:

Grenzacherstrasse 124

Basel 4070

Switzerland

Business Description
Founded in1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalized healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice. In recognizing our endeavor ...
More
Financial Reporting
Reporting Status
International Reporting: SIX Swiss Exchange
Audited Financials
Audited
CIK
0000896566
Fiscal Year End
12/31
Company Disclosure Website
Company Officers & Contacts
Thomas Schinecker
CEO

Teresa Graham
CEO

Matt Sause
CEO

Alan Hippe
CFO, CIO

Cristina A. Wilbur
Chief Human Resources Officer

Presently, Cristina A. Wilbur occupies the position of Chairman for International School of the Basel Region AG and Head-Group Human Resources at Roche Holding AG. In the past Ms. Wilbur was Global Head-Human Resources & Senior VP at Roche Diagnostics (Switzerland) AG, Head-Group Human Resources at Roche Group, Director-Human Resources of EG&G, Inc., Director-Human Resources of PerkinElmer Optoelectronics, Inc. and Director-Human Resources for Roche Diagnostics Corp. Ms. Wilbur received an undergraduate degree from California Polytechnic State University (San Luis Obispo).

Claudia Bockstiegel
General Counsel

Sonya Schwab
Administrator

Bruno Eschli
Head of IR

Board of Directors
Severin Schwan
Chairman

Andre Hoffmann
Vice Chairman

Jorg Duschmale

Claudia Sussmuth Dyckerhoff

Patrick Frost

Anita Hauser

Akiko Iwasaki

Richard Lifton

Jemilah Mahmood

Bernard Poussot

Mark Schneider

Other Company Insiders

None

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
KPMG Accountants N.V.

Ganghoferstrasse 29

Munich 80339

Germany

Securities Counsel
Davis Polk & Wardwell LLP

450 Lexington Ave

New York, NY 10017

Profile Data
SIC - Industry Classification
2834 - Pharmaceutical preparations
Incorporation Information
CH, 1896
Employees
10,361 as of 12/31/2022
Shell
No
Products and Services

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. In recent years, Roche has invested in genomic profiling and real-world data partnerships and has become an industry-leading partner for medical insights.

Company Facilities

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.

Company Notes
Sponsored for OTCQX by J.P. Morgan on 10/1/2015
OTCQX Best Market Logo
Joined OTCQX 11/2007
The Company Profile data was verified by the issuer within the previous 6 months.
This security is not a Penny Stock as defined in SEC Rule 240.3a51-1.
This company has certified to OTC Markets Group that it is eligible to rely on the exemption from registration under Securities and Exchange Act Rule 12g3-2(b).
Securities
Other Roche Holding Ltd Securities
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.